K11-linked ubiquitin chains as novel regulators of cell division

Trends in Cell Biology

Volumn 21, Issue 11, 2011, Pages 656-663

  Wickliffe, Katherine E ^a   Williamson, Adam ^a   Meyer, Hermann Josef ^a   Kelly, Aileen ^a   Rape, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K11 LINKED UBIQUITIN; LYSINE; UBIQUITIN; UNCLASSIFIED DRUG;

CELL CYCLE; CELL DIVISION; DROSOPHILA; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; XENOPUS; YEAST;

ANIMALS; CELL DIVISION; HUMANS; POLYUBIQUITIN; PROTEIN MULTIMERIZATION; UBIQUITIN-PROTEIN LIGASE COMPLEXES; UBIQUITINATED PROTEINS; UBIQUITINATION;

EUKARYOTA;

EID: 80755153309     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2011.08.008     Document Type: Review

References (86)

1. Schulman B.A., Harper J.W. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 2009, 10:319-331.
2. Ye Y., Rape M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 2009, 10:755-764.
3. Deshaies R.J., Joazeiro C.A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 2009, 78:399-434.
4. Deribe Y.L., et al. Post-translational modifications in signal integration. Nat. Struct. Mol. Biol. 2010, 17:666-672.
5. Chau V., et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989, 243:1576-1583.
6. Thrower J.S., et al. Recognition of the polyubiquitin proteolytic signal. EMBO J. 2000, 19:94-102.
7. Deng L., et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103:351-361.
8. VanDemark A.P., et al. Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell 2001, 105:711-720.
9. Jin L., et al. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 2008, 133:653-665.
10. Iwai K., Tokunaga F. Linear polyubiquitination: a new regulator of NF-kappaB activation. EMBO Rep. 2009, 10:706-713.
11. Matsumoto M.L., et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol. Cell 2010, 39:477-484.
12. Dynek J.N., et al. c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO J. 2010, 29:4198-4209.
13. Boname J.M., et al. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 2010, 11:210-220.
14. Baboshina O.V., Haas A.L. Novel multiubiquitin chain linkages catalyzed by the conjugating enzymes E2EPF and RAD6 are recognized by 26 S proteasome subunit 5. J. Biol. Chem. 1996, 271:2823-2831.
15. Peng J., et al. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 2003, 21:921-926.
16. Xu P., et al. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009, 137:133-145.
17. Ziv I., et al. A perturbed ubiquitin landscape distinguishes between ubiquitin in trafficking and in proteolysis. Mol. Cell. Proteomics 2011, 10. M111.009753.
18. Bennett E.J., et al. Global changes to the ubiquitin system in Huntington's disease. Nature 2007, 448:704-708.
19. Dammer E.B., et al. Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J. Biol. Chem. 2011, 286:10457-10465.
20. Kaiser S.E., et al. Protein standard absolute quantification (PSAQ) method for the measurement of cellular ubiquitin pools. Nat. Methods 2011, 8:691-696.
21. Williamson A., et al. Identification of a physiological E2 module for the human anaphase-promoting complex. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:18213-18218.
22. Wu T., et al. UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1355-1360.
23. Glotzer M., et al. Cyclin is degraded by the ubiquitin pathway. Nature 1991, 349:132-138.
24. Pfleger C.M., Kirschner M.W. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev. 2000, 14:655-665.
25. da Fonseca P.C., et al. Structures of APC/C(Cdh1) with substrates identify Cdh1 and Apc10 as the D-box co-receptor. Nature 2011, 470:274-278.
26. Wolthuis R., et al. Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A. Mol. Cell 2008, 30:290-302.
27. Hayes M.J., et al. Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C. Nat. Cell Biol. 2006, 8:607-614.
28. Yu H., et al. Identification of a novel ubiquitin-conjugating enzyme involved in mitotic cyclin degradation. Curr. Biol. 1996, 6:455-466.
29. Townsley F.M., et al. Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:2362-2367.
30. Rape M., Kirschner M.W. Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. Nature 2004, 432:588-595.
31. Williamson A. Regulation of ubiquitin chain initiation to determine the timing of substrate degradation. Mol. Cell 2011, 42:744-757.
32. Kirkpatrick D.S., et al. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat. Cell Biol. 2006, 8:700-710.
33. Machida Y.J., et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 2006, 23:589-596.
34. Wagner K.W., et al. Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 2004, 23:6621-6629.
35. Fujita T., et al. Clinicopathological relevance of UbcH10 in breast cancer. Cancer Sci. 2008, 100:238-248.
36. Berlingieri M.T., et al. UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene 2007, 26:2136-2140.
37. Mathe E., et al. The E2-C vihar is required for the correct spatiotemporal proteolysis of cyclin B and itself undergoes cyclical degradation. Curr. Biol. 2004, 14:1723-1733.
38. Zeng X., et al. Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell 2010, 18:382-395.
39. Tang Z., et al. APC2 Cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex. Mol. Biol. Cell 2001, 12:3839-3851.
40. Summers M.K., et al. The unique N terminus of the UbcH10 E2 enzyme controls the threshold for APC activation and enhances checkpoint regulation of the APC. Mol. Cell 2008, 31:544-556.
41. King R.W., et al. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol. Biol. Cell 1996, 7:1343-1357.
42. Lin Y., et al. Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10. J. Biol. Chem. 2002, 277:21913-21921.
43. Pierce N.W., et al. Detection of sequential polyubiquitylation on a millisecond timescale. Nature 2009, 462:615-619.
44. Rape M., et al. The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 2006, 124:89-103.
45. Wickliffe K.E., et al. The mechanism of linkage-specific ubiquitin chain elongation by a single-subunit E2. Cell 2011, 144:769-781.
46. Whitfield M.L., et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 2002, 13:1977-2000.
47. Miniowitz-Shemtov S., et al. ATP is required for the release of the anaphase-promoting complex/cyclosome from inhibition by the mitotic checkpoint. Proc. Natl. Acad. Sci. U.S.A. 2010, 107. 5351-5316.
48. Reddy S.K., et al. Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 2007, 446:921-925.
49. van Ree J.H., et al. Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation. J. Cell Biol. 2010, 188:83-100.
50. Yamanaka A., et al. Cell cycle-dependent expression of mammalian E2-C regulated by the anaphase-promoting complex/cyclosome. Mol. Biol. Cell 2000, 11:2821-2831.
51. Walker A., et al. UbcH10 has a rate-limiting role in G1 phase but might not act in the spindle checkpoint or as part of an autonomous oscillator. J. Cell Sci. 2008, 121:2319-2326.
52. Garnett M.J., et al. UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit. Nat. Cell Biol. 2009, 11:1363-1369.
53. Jung C.R., et al. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat. Med. 2006, 12:809-816.
54. Bremm A., et al. Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat. Struct. Mol. Biol. 2010, 17:939-947.
55. Saha A., et al. Essential role for ubiquitin-ubiquitin-conjugating enzyme interaction in ubiquitin discharge from Cdc34 to substrate. Mol. Cell 2011, 42:75-83.
56. Ceccarelli D.F., et al. An allosteric inhibitor of the human cdc34 ubiquitin-conjugating enzyme. Cell 2011, 145:1075-1087.
57. Hamilton K.S., et al. Structure of a conjugating enzyme-ubiquitin thiolester intermediate reveals a novel role for the ubiquitin tail. Structure 2001, 9:897-904.
58. Kamadurai H.B., et al. Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex. Mol. Cell 2009, 36:1095-1102.
59. Reverter D., Lima C.D. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 2005, 435:687-692.
60. Bosanac I., et al. Modulation of K11-linkage formation by variable loop residues within UbcH5A. J. Mol. Biol. 2011, 408:420-431.
61. Yunus A.A., Lima C.D. Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway. Nat. Struct. Mol. Biol. 2006, 13:491-499.
62. Tedesco D., et al. The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition. Neoplasia 2007, 9:601-613.
63. Komander D., et al. Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 2009, 10:550-563.
64. Neumann B., et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 2010, 464:721-772.
65. Enesa K., et al. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 2008, 283:7036-7045.
66. Sowa M.E., et al. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138:389-403.
67. Kaelin W.G. Von Hippel-Lindau disease. Annu. Rev. Pathol. 2007, 2:145-173.
68. Matyskiela M.E., Morgan D.O. Analysis of activator-binding sites on the APC/C supports a cooperative substrate-binding mechanism. Mol. Cell 2009, 34:68-80.
69. Stegmeier F., et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 2007, 446:876-881.
70. Nilsson J., et al. The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. Nat. Cell Biol. 2008, 10:1411-1420.
71. Yang Y., et al. A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation. Science 2009, 326:575-578.
72. Zhang Y., et al. Overexpression of ubiquitin specific protease 44 (USP44) induces chromosomal instability and is frequently observed in human T-cell leukemia. PLoS ONE 2011, 6:e23389.
73. Huang X., et al. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. Mol. Cell 2011, 42:511-523.
74. Rape M., et al. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 2001, 107:667-677.
75. Alexandru G., et al. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 2008, 134:804-816.
76. van Wijk S.J., Timmers H.T. The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J. 2010, 24:981-993.
77. Rodrigo-Brenni M.C., et al. Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin. Mol. Cell 2010, 39:548-559.
78. Kalab P., Heald R. The RanGTP gradient - a GPS for the mitotic spindle. J. Cell Sci. 2008, 121:157715-157786.
79. Daum J.R., et al. Cohesion fatigue induces chromatid separation in cells delayed at metaphase. Curr. Biol. 2011, 21:1018-1024.
80. Huang H.C., et al. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 2009, 16:347-358.
81. Song L., Rape M. Regulated degradation of spindle assembly factors by the anaphase-promoting complex. Mol. Cell 2010, 38:369-382.
82. Ribbeck K., et al. NuSAP, a mitotic RanGTP target that stabilizes and cross-links microtubules. Mol. Biol. Cell 2006, 17:2646-2660.
83. Sillje H.H., et al. HURP is a Ran-importin beta-regulated protein that stabilizes kinetochore microtubules in the vicinity of chromosomes. Curr. Biol. 2006, 16:731-742.
84. Olsen S.K., et al. Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature 2010, 463:906-912.
85. Rotin D., Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2009, 10:398-409.
86. Wenzel D.M., et al. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 2011, 474:105-108.